Rmb Capital Management, LLC Amgen Inc Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Rmb Capital Management, LLC holds 49,170 shares of AMGN stock, worth $12.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

49,170

Previous 50,851 3.31%

Holding current value

$12.8 Million

Previous $15.9 Million 0.28%

% of portfolio

0.37%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $520,067 - $567,135	-1,681 Reduced 3.31%	49,170 $15.8 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $844,478 - $1.03 Million	-3,214 Reduced 5.94%	50,851 $15.9 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $169,388 - $204,472	-630 Reduced 1.15%	54,065 $15.4 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $757,639 - $854,706	-2,963 Reduced 5.14%	54,695 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $83,961 - $104,240	384 Added 0.67%	57,658 $15.5 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $79,494 - $94,000	-371 Reduced 0.64%	57,274 $12.7 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $413,647 - $504,166	-1,832 Reduced 3.08%	57,645 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $794,047 - $1.01 Million	-3,467 Reduced 5.51%	59,477 $15.6 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $811,422 - $915,137	-3,615 Reduced 5.43%	62,944 $14.2 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $757,420 - $842,877	-3,283 Reduced 4.7%	66,559 $16.2 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $652,986 - $722,373	2,978 Added 4.45%	69,842 $16.9 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $125,493 - $143,615	631 Added 0.95%	66,864 $15 Million
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $789,644 - $925,164	3,720 Added 5.95%	66,233 $14.1 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $353,172 - $391,819	1,512 Added 2.48%	62,513 $15.2 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $228,567 - $266,358	1,030 Added 1.72%	61,001 $15.2 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $1.54 Million - $1.84 Million	7,138 Added 13.51%	59,971 $13.8 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $26,750 - $29,748	-114 Reduced 0.22%	52,833 $13.4 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $905,574 - $1.11 Million	-4,578 Reduced 7.96%	52,947 $12.5 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $2.29 Million - $3.04 Million	-12,560 Reduced 17.92%	57,525 $11.7 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.12 Million - $1.44 Million	-5,925 Reduced 7.8%	70,085 $16.9 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $157,047 - $188,175	-902 Reduced 1.17%	76,010 $14.7 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $287,390 - $336,886	-1,724 Reduced 2.19%	76,912 $14.2 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $1.29 Million - $1.45 Million	-7,134 Reduced 8.32%	78,636 $14.9 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $81,172 - $94,753	455 Added 0.53%	85,770 $16.7 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $101,909 - $114,889	-550 Reduced 0.64%	85,315 $17.7 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $1.13 Million - $1.27 Million	-6,784 Reduced 7.32%	85,865 $0
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $1.32 Million - $1.54 Million	7,788 Added 9.18%	92,649 $15.8 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $620,978 - $693,822	3,679 Added 4.53%	84,861 $14.8 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $501,702 - $572,809	-2,999 Reduced 3.56%	81,182 $15.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	84,181	84,181 $14.5 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account

Rmb Capital Management, LLC Amgen Inc Transaction History